Tag Archives: Zyprexa

Lawyer who took on drug giant Eli Lilly & won has a new target—the psychiatric industry & drugging of foster kids

An Alaska attorney who has gone up against a drug giant and won has a new target. Jim Gottstein is taking on psychiatry in Alaska for over-prescribing medicine to children. Gottstein was the attorney who forced Eli Lilly to pay more than $1 billion in settlements over the anti-psychotic drug Zyprexa. He also heads up a group called the Law Project for Psychiatric Rights, which filed the lawsuit. The group claims over-prescribing is disabling children for life.

Drugmaker that got kickbacks for giving antipsychotics to nursing home patients deserves “a special place in hell”

There really should be a special place in hell for pharmaceutical manufacturers who make money by exploiting the weakest and most vulnerable of patients: old people with dementia…. Johnson & Johnson paid kickbacks to the nation’s largest nursing home pharmacy to increase the number of elderly patients taking the antipsychotic Risperdal and several other medications, according to a complaint filed Friday by the office of the United States attorney in Boston.

Pharma Funded FDA’s Christmas Present to Drug Companies: Approving use of deadly antipsychotic drugs for kids

Many states have sued over the cost of atypical antipsychotic drugs, especially the cost of treating the diabetes and metabolic disorders they cause, which has decimated Medicaid budgets. Yet now the FDA gives pharma the Christmas present of approving Seroquel and Zyprexa for children and hence, Medicaid reimbursement even as its own Division of Pharmacovigilance (DPV) reported a “a direct association between adverse metabolic effects of treatment with atypical antipsychotics” and children!

Op Ed: New Year’s Resolutions for the Drug Industry for 2010

Clearly the drug industry needs New Year’s Resolutions–and to honor them better than the Corporate Integrity Agreements with the government it keeps breaking. How about: “We will stop upgrading anxiety to depression, depression to bipolar disorder and bipolar disorder to ‘treatment resistant depression’ to sell drugs. We will admit that studies are beginning to show that the reason depression is sometimes treatment resistant is because it wasn’t depression to begin with but consumer advertising.”